[1]
|
Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. https://doi.org/10.3322/caac.21763
|
[2]
|
Cao, W., Chen, H.D., Yu, Y.W., et al. (2021) Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal, 134, 783-791. https://doi.org/10.1097/CM9.0000000000001474
|
[3]
|
张思维, 郑荣寿, 孙可欣, 等. 2016年中国恶性肿瘤分地区发病和死亡估计: 基于人群的肿瘤登记数据分析[J]. 中国肿瘤, 2023, 32(5): 321-332.
|
[4]
|
Chen, Y., Li, J., Jin, L., Lei, K., et al. (2019) Fibulin-5 Contributes to Colorectal Cancer Cell Apoptosis via the ROS/MAPK and Akt Signal Pathways by Downregulating Transient Receptor Potential Cation Channel Subfamily V Member 1. Journal of Cellular Biochemistry, 120, 17838-17846. https://doi.org/10.1002/jcb.29051
|
[5]
|
Eekhoff, J.D., Steenbock, H., Berke, I.M., et al. (2021) Dysregulated Assembly of Elastic Fibers in Fibulin-5 Knockout Mice Results in a Tendon-Specific Increase in Elastic Modulus. Journal of the Mechanical Behavior of Biomedical Materials, 113, Article ID: 104134. https://doi.org/10.1016/j.jmbbm.2020.104134
|
[6]
|
Ikelle, L., Naash, M.I. and Al-Ubaidi, M.R. (2018) Role of Fibulins 2 and 5 in Retinal Development and Maintenance. Advances in Experimental Medicine and Biology, 1074, 275-280. https://doi.org/10.1007/978-3-319-75402-4_33
|
[7]
|
Chen, Z., Wang, Z., Chen, J. and Li, Z. (2018) Fibulin-5 Is Down-Regulated in Colorectal Cancer and Correlated with Clinicopathologic Characteristics. Clinical Laboratory, 64, 25-31. https://doi.org/10.7754/Clin.Lab.2017.170519
|
[8]
|
Lu, P., Weaver, V.M. and Werb, Z. (2012) The Extracellular Matrix: A Dynamic Niche in Cancer Progression. Journal of Cell Biology, 196, 395-406. https://doi.org/10.1083/jcb.201102147
|
[9]
|
Mohamedi, Y., Fontanil, T., Cobo, T., et al. (2019) Antitumor Potential of Fibulin-5 in Breast Cancer Cells Depends on Its RGD Cell Adhesion Motif. Cellular Physiology & Biochemistry, 53, 87-100. https://doi.org/10.33594/000000123
|
[10]
|
Tian, W., Luo, Y., Tang, Y., Kong, Y., et al. (2023) Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. International Journal of Biological Sciences, 19, 1645-1663. https://doi.org/10.7150/ijbs.81939
|
[11]
|
Bian, X., Yin, S., Yin, X., Fang, T., et al. (2023) Clinical and Biological Significances of FBLN5 in Gastric Cancer. Cancers, 15, Article 553. https://doi.org/10.3390/cancers15020553
|
[12]
|
Yan, B., Hu, Y., Ma, T. and Wang, Y. (2018) IDH1 Mutation Promotes Lung Cancer Cell Proliferation through Methylation of Fibulin-5. Open Biology, 8, Article ID: 180086. https://doi.org/10.1098/rsob.180086
|
[13]
|
Davila-Avila, N., Muñiz-Ruvalcaba, F.P., Hernandez-Zimbron, L.F., et al. (2020) Expression of Fibulin-2 and Fibulin-5 on Subretinal Fluid in Human Primary Rhegmatogenous Retinal Detachment. Experimental Eye Research, 194, Article ID: 107992. https://doi.org/10.1016/j.exer.2020.107992
|
[14]
|
Kowal, R.C., Richardson, J.A., Miano, J.M. and Olson, E.N. (1999) EVEC, A Novel Epidermal Growth Factor-Like Repeat-Containing Protein Upregulated in Embryonic and Diseased Adult Vasculature. Circulation Research, 84, 1166-1176. https://doi.org/10.1161/01.RES.84.10.1166
|
[15]
|
Nakamura, T., Ruiz-Lozano, P., Lindner, V., et al. (1999) DANCE, A Novel Secreted RGD Protein Expressed in Developing, Atherosclerotic, and Balloon-Injured Arteries. Journal of Biological Chemistry, 274, 22476-22483. https://doi.org/10.1074/jbc.274.32.22476
|
[16]
|
Tsuda, T. (2018) Extracellular Interactions between Fibulins and Transforming Growth Factor (TGF)-β in Physiological and Pathological Conditions. International Journal of Molecular Sciences, 19, Article 2787. https://doi.org/10.3390/ijms19092787
|
[17]
|
Schneider, R., Jensen, S.A., Whiteman, P., et al. (2010) Biophysical Characterisation of Fibulin-5 Proteins Associated with Disease. Journal of Molecular Biology, 401, 605-617. https://doi.org/10.1016/j.jmb.2010.06.039
|
[18]
|
Winship, A.L., Rainczuk, K., Ton, A. and Dimitriadis, E. (2016) Fibulin-5 Localisation in Human Endometrial Cancer Shifts From Epithelial to Stromal with Increasing Tumour Grade, and Silencing Promotes Endometrial Epithelial Cancer Cell Proliferation. Oncology Letters, 12, 651-657. https://doi.org/10.3892/ol.2016.4650
|
[19]
|
Tu, K., Dou, C., Zheng, X., et al. (2014) Fibulin-5 Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Down-Regulating Matrix Metalloproteinase-7 Expression. BMC Cancer, 14, Article No. 938. https://doi.org/10.1186/1471-2407-14-938
|
[20]
|
曹贵华, 闫永吉, 陈戬, 等. Fibulin-5基因沉默对人膀胱癌细胞5637增殖活力及迁移力的影响[J]. 华西医学, 2018, 33(4): 417-422.
|
[21]
|
Tang, J.C., Liu, J.H., Liu, X.L., Liang, X. and Cai, X.J. (2015) Effect of Fibulin-5 on Adhesion, Migration and Invasion of Hepatocellular Carcinoma Cells via an Integrin-Dependent Mechanism. World Journal of Gastroenterology, 21, 11127-11140. https://doi.org/10.3748/wjg.v21.i39.11127
|
[22]
|
Tang, J.C., Xie, A.Y. and Cai, X.J. (2014) [Diverse Functions of Fibulin-5 in Tumors]. Molecular Biology, 48, 875-880. https://doi.org/10.1134/S002689331406017X
|
[23]
|
Yuan, R., Li, Y., Yang, B., Jin, Z., et al. (2021) LOXL1 Exerts Oncogenesis and Stimulates Angiogenesis through the LOXL1-FBLN5/αVβ3 Integrin/FAK-MAPK Axis in ICC. Nucleic Acids, 23, 797-810. https://doi.org/10.1016/j.omtn.2021.01.001
|
[24]
|
Manders, D.B., Kishore, H.A., Gazdar, A.F., et al. (2018) Dysregulation of Fibulin-5 and Matrix Metalloproteases in Epithelial Ovarian Cancer. Oncotarget, 9, 14251-14267. https://doi.org/10.18632/oncotarget.24484
|
[25]
|
Eguchi, T., Csizmadia, E., Kawai, H., Sheta, M., et al. (2022) SCAND1 Reverses Epithelial-To-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration. Cells, 11, Article 3993. https://doi.org/10.3390/cells11243993
|
[26]
|
Huang, Y., Hong, W. and Wei, X. (2022) The Molecular Mechanisms and Therapeutic Strategies of EMT in Tumor Progression and Metastasis. Journal of Hematology & Oncology, 15, Article No. 129. https://doi.org/10.1186/s13045-022-01347-8
|
[27]
|
Chen, X., Song, X., Yue, W., Chen, D., Yu, J., Yao, Z. and Zhang, L. (2015) Fibulin-5 Inhibits Wnt/β-Catenin Signaling in Lung Cancer. Oncotarget, 6, 15022-15034. https://doi.org/10.18632/oncotarget.3609
|
[28]
|
Lee, Y.H., Albig, A.R., Regner, M., et al. (2008) Fibulin-5 Initiates Epithelial-Mesenchymal Transition (EMT) and Enhances EMT Induced by TGF-β in Mammary Epithelial Cells via a MMP-Dependent Mechanism. Carcinogenesis, 29, 2243-2251. https://doi.org/10.1093/carcin/bgn199
|
[29]
|
冯星星, 吉奇, 李双莲, 等. FBLN-5与肿瘤关系的研究进展[J]. 吉林医学, 2020, 41(7): 1707-1710.
|
[30]
|
景娈恋, 刘倩. FBLN5在前列腺癌组织中的表达及对前列腺癌细胞增殖、侵袭的影响[J]. 中国男科学杂志, 2023, 37(3): 59-63.
|
[31]
|
Spill, F., Reynolds, D.S., Kamm, R.D. and Zaman, M.H. (2016) Impact of the Physical Microenvironment on Tumor Progression and Metastasis. Current Opinion in Biotechnology, 40, 41-48. https://doi.org/10.1016/j.copbio.2016.02.007
|
[32]
|
Del Prete, A., Schioppa, T., Tiberio, L., Stabile, H. and Sozzani, S. (2017) Leukocyte Trafficking in Tumor Microenvironment. Current Opinion in Biotechnology, 35, 40-47. https://doi.org/10.1016/j.coph.2017.05.004
|
[33]
|
Xiao, Y. and Yu, D. (2021) Tumor Microenvironment as a Therapeutic Target in Cancer. Pharmacology & Therapeutics, 221, Article ID: 107753. https://doi.org/10.1016/j.pharmthera.2020.107753
|
[34]
|
Heo, J.H., Song, J.Y., Jeong, J.Y., et al. (2016) Fibulin-5 Is a Tumour Suppressor Inhibiting Cell Migration and Invasion in Ovarian Cancer. Journal of Clinical Pathology, 69, 109-116. https://doi.org/10.1136/jclinpath-2015-203129
|
[35]
|
Hu, Z., Ai, Q., Xu, H., et al. (2011) Fibulin-5 Is Down-Regulated in Urothelial Carcinoma of Bladder and Inhibits Growth and Invasion of Human Bladder Cancer Cell Line 5637. Urologic Oncology: Seminars and Original Investigations, 29, 430-435. https://doi.org/10.1016/j.urolonc.2009.06.004
|
[36]
|
杨晔, 党荣广, 张静, 等. 扣针蛋白5 (FBLN5)在肺癌组织中表达及对肺癌细胞增殖,迁移及侵袭的影响[J]. 广西医科大学学报, 2022, 39(7): 1093-1099.
|
[37]
|
Wang, M., Topalovski, M., Toombs, J.E., et al. (2015) Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer. Cancer Research, 75, 5058-5069. https://doi.org/10.1158/0008-5472.CAN-15-0744
|
[38]
|
Topalovski, M., Hagopian, M., Wang, M. and Brekken, R.A. (2016) Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer. Journal of Biological Chemistry, 291, 22244-22252. https://doi.org/10.1074/jbc.M116.730945
|
[39]
|
Xiao, W., Zhou, S., Xu, H., et al. (2022) [Corrigendum] Nogo-B Promotes the Epithelial-Mesenchymal Transition in HeLa Cervical Cancer Cells via Fibulin-5. Oncology Reports, 47, Article No. 100. https://doi.org/10.3892/or.2022.8311
|
[40]
|
Claus, S., Fischer, J., Mégarbané, H., et al. (2008) A P.C217R Mutation in Fibulin-5 from Cutis Laxa Patients Is Associated with Incomplete Extracellular Matrix Formation in a Skin Equivalent Model. Journal of Investigative Dermatology, 128, 1442-1450. https://doi.org/10.1038/sj.jid.5701211
|
[41]
|
周锐. Fibulin-5基因在人食管癌中的表达、作用及机制研究[D]: [博士学位论文]. 苏州: 苏州大学, 2018.
|
[42]
|
何恒, 虞玉存, 何咏, 等. Fibulin-5对膀胱癌细胞克隆形成能力及细胞中ROS、MMPs水平的影响[J]. 现代肿瘤医学, 2019, 27(8): 1308-1314.
|
[43]
|
Mahajan, D., Kancharla, S., Kolli, P., et al. (2021) Role of Fibulins in Embryonic Stage Development and Their Involvement in Various Diseases. Biomolecules, 11, Article 685. https://doi.org/10.3390/biom11050685
|
[44]
|
Chan, W., Ismail, H., Mayaki, D., et al. (2016) Fibulin-5 Regulates Angiopoietin-1/Tie-2 Receptor Signaling in Endothelial Cells. PLOS ONE, 11, e0156994. https://doi.org/10.1371/journal.pone.0156994
|
[45]
|
Karanis, M., Koksal, H., Ates, E., et al. (2019) Clinical Importance of Fibulin-5 Immunohistochemical Staining in Breast Lesions. Polish Journal of Pathology, 70, 259-263. https://doi.org/10.5114/pjp.2019.93127
|
[46]
|
Jamasbi, E., Hamelian, M., Hossain, M.A. and Varmira, K. (2022) The Cell Cycle, Cancer Development and Therapy. Molecular Biology Reports, 49, 10875-10883. https://doi.org/10.1007/s11033-022-07788-1
|
[47]
|
Gérard, C., Tyson, J.J., Coudreuse, D. and Novák, B. (2015) Cell Cycle Control by a Minimal Cdk Network. PLOS Computational Biology, 11, e1004056. https://doi.org/10.1371/journal.pcbi.1004056
|
[48]
|
王凡, 张菁菁, 赵新军, 等. 模型化研究药物小分子阻滞细胞周期[J]. 原子与分子物理学报, 2024, 41(5): 9-16.
|
[49]
|
Schiemann, W.P., Blobe, G.C., Kalume, D.E., Pandey, A. and Lodish, H.F. (2002) Context-Specific Effects of Fibulin-5 (DANCE/EVEC) on Cell Proliferation, Motility, and Invasion. Fibulin-5 Is Induced by Transforming Growth Factor-Beta and Affects Protein Kinase Cascades. Journal of Biological Chemistry, 277, 27367-27377. https://doi.org/10.1074/jbc.M200148200
|